View ValuationPrevas 将来の成長Future 基準チェック /46Prevas利益と収益がそれぞれ年間28%と6.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に19.7% 27.6%なると予測されています。主要情報28.0%収益成長率27.64%EPS成長率IT 収益成長13.6%収益成長率6.8%将来の株主資本利益率19.66%アナリストカバレッジLow最終更新日10 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • 10hNew minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €86.3m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€86.3m market cap, or US$99.2m).お知らせ • May 22Prevas AB Resolves Dividend for the Year Ended December 2025, Payable on May 26, 2026In accordance with the proposal of the Prevas AB Board of Directors, the Annual General Meeting held on, May 19, 2026 resolved on a dividend of SEK 4 per share for the 2025 financial year. The record date for the dividend was set to May 21, 2026, and the dividend is expected to be distributed through Euroclear Sweden AB on May 26, 2026.お知らせ • May 05+ 2 more updatesPrevas AB to Report First Half, 2026 Results on Jul 17, 2026Prevas AB announced that they will report first half, 2026 results on Jul 17, 2026お知らせ • Apr 21Prevas AB to Report Q1, 2026 Results on May 05, 2026Prevas AB announced that they will report Q1, 2026 results at 8:30 AM, Central European Standard Time on May 05, 2026お知らせ • Feb 11Prevas AB Proposes Dividend for the Year Ended December 2025Th Board of Prevas AB proposed a dividend of SEK 4.00 per share (SEK 4.75) per share for the year ended December 2025.お知らせ • Jan 28Prevas Strengthens Customer Support with AI AssistancePrevas AB announced taking the next step by integrating AI into its operations and support services - a move that improves both delivery quality and the work environment for support staff. Prevas currently manages the operations and support of production-critical IT systems for several major industrial clients globally. To meet high demands for availability and quick response times, an AI-powered solution is being implemented. It enables rapid access to and reuse of information from previous cases, documentation, and system logs. The AI solution supports Prevas' support teams in their daily work. A large portion of information handling and documentation can be automated, reducing the need for manual searches and repetitive tasks. The AI support is not a standalone project, but a fully integrated part of Prevas' comprehensive offering in operations and system management. It is primarily used to quickly retrieve past solutions, compile information, and prioritize tasks. As the technology is integrated with more systems, its capabilities are expected to become even more powerful and adaptive. The next step is to automate more parts of the support workflow - from case intake and prioritization to AI-driven monitoring that detects anomalies before operations are affected.お知らせ • Nov 04Prevas AB, Annual General Meeting, Jan 31, 2026Prevas AB, Annual General Meeting, Jan 31, 2026.お知らせ • Jul 03Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab.Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025. The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025. Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab on April 28, 2025. Prevas has received the necessary regulatory approvals for the acquisition. The acquisition of OIM Sweden AB is expected to have a marginally positive impact on Prevas’ earnings per share in the current fiscal year.お知らせ • May 15Prevas AB Announces Dividend for the Financial Year 2024, Payable on May 21, 2025Prevas AB Board of Directors' proposal, on a dividend of SEK 4.75 per share for the financial year 2024. The record date for the dividend was set to May 16, 2025, and the dividend is expected to be distributed by Euroclear Sweden AB on May 21, 2025.お知らせ • May 06+ 2 more updatesPrevas AB to Report First Half, 2025 Results on Jul 17, 2025Prevas AB announced that they will report first half, 2025 results on Jul 17, 2025お知らせ • May 05Prevas AB to Report Q1, 2025 Results on May 06, 2025Prevas AB announced that they will report Q1, 2025 results at 8:30 AM, Central European Standard Time on May 06, 2025お知らせ • Apr 29Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab.Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025. The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025.お知らせ • Apr 11Prevas AB Proposes Dividend, Payable on May 21, 2025Prevas AB at its Annual General Meeting to be held on May 14, 2025, Board of Directors proposed that a dividend of SEK 4.75 per share, totaling SEK 61,204,842.50, will be paid and that the remaining available earnings of approximately SEK 167,943,121, be carried forward. The record date for the payment is proposed to be May 16, 2025, and if the Annual General Meeting decides in accordance with the proposal, the dividend is expected to be paid through Euroclear Sweden AB on May 21, 2025.お知らせ • Feb 18Biosensor Launches Enhanced Detection System for Border Controls Biosens®?900Biosensor launched an enhanced detection system for drugs and explosive substances from the Biosensor Applications - will be introduced during the spring. The instrument has been developed, tested and certified in close cooperation with Prevas. The BIOSENS®?900 is a portable instrument that is used to detect traces of drugs and explosives. The analysis is used to confirm suspected and make it easier to continue searching for prohibited substances. The system is used by customers all over the world, above all for checking goods, containers and luggage at border controls and customs filters. The Biosens series has been on the market for more than 20 years, with the BIOSENS®?900 representing the third generation of the instrument. Prevas has long supported Biosensor Applications with the management and further development of the system's software platform, and they were also commissioned to assist with the development and launch of the new instrument model. The BIOSENS®? 900 has been updated in several areas. The system is now battery-powered and the handling of consumables has been simplified. Its size and weight have been reduced by more than 30%, and the instrument has gained an entirely new platform for electronics and mechanics. The software platform has also been adapted to support new features and future-proof production.お知らせ • Feb 11Prevas AB Proposes Dividend for the Year Ended December 2024The board of Prevas AB proposed a dividend of SEK 4.75 per share (SEK 4.75) for the year ended December 2024.お知らせ • Feb 06Prevas AB to Report Fiscal Year 2024 Results on Feb 11, 2025Prevas AB announced that they will report fiscal year 2024 results at 8:30 AM, Central European Standard Time on Feb 11, 2025お知らせ • Nov 05Prevas AB, Annual General Meeting, May 14, 2025Prevas AB, Annual General Meeting, May 14, 2025.業績と収益の成長予測DB:J89 - アナリストの将来予測と過去の財務データ ( )SEK Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281,953160201211212/31/20271,814135174183212/31/20261,68910412112923/31/20261,62368115122N/A12/31/20251,62871136144N/A9/30/20251,62773148156N/A6/30/20251,62465121128N/A3/31/20251,61181133142N/A12/31/20241,58791128137N/A9/30/20241,55499119125N/A6/30/20241,513111176182N/A3/31/20241,495110164169N/A12/31/20231,483118160164N/A9/30/20231,473122145151N/A6/30/20231,446125117124N/A3/31/20231,40312899105N/A12/31/20221,32411998103N/A9/30/20221,25512395100N/A6/30/20221,224122133140N/A3/31/20221,202112100105N/A12/31/20211,1871037379N/A9/30/20211,070778185N/A6/30/2021976572425N/A3/31/2021856527880N/A12/31/202077246116118N/A9/30/20207834599101N/A6/30/202080047111113N/A3/31/2020808418286N/A12/31/201979632N/A59N/A9/30/201979416N/A48N/A6/30/201977910N/A35N/A3/31/20197807N/A12N/A12/31/20187715N/A18N/A9/30/20187549N/A11N/A6/30/201874710N/A5N/A3/31/20187319N/A6N/A12/31/201773511N/A8N/A9/30/20177242N/A11N/A6/30/20177150N/A-2N/A3/31/2017719-2N/A-2N/A12/31/2016697-7N/A1N/A9/30/2016697-7N/A-1N/A6/30/2016700-5N/A7N/A3/31/2016692-7N/A9N/A12/31/2015701-8N/A4N/A9/30/20157050N/A14N/A6/30/20157186N/A21N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: J89の予測収益成長率 (年間28% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: J89の収益 ( 28% ) はGerman市場 ( 17% ) よりも速いペースで成長すると予測されています。高成長収益: J89の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: J89の収益 ( 6.8% ) German市場 ( 6.7% ) よりも速いペースで成長すると予測されています。高い収益成長: J89の収益 ( 6.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: J89の 自己資本利益率 は、3年後には低くなると予測されています ( 19.7 %)。成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 07:43終値2026/06/17 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Prevas AB 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Stefan KnutssonABG Sundal Collier Sponsorednull nullABG Sundal Collier Sponsored
New Risk • 10hNew minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €86.3m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€86.3m market cap, or US$99.2m).
お知らせ • May 22Prevas AB Resolves Dividend for the Year Ended December 2025, Payable on May 26, 2026In accordance with the proposal of the Prevas AB Board of Directors, the Annual General Meeting held on, May 19, 2026 resolved on a dividend of SEK 4 per share for the 2025 financial year. The record date for the dividend was set to May 21, 2026, and the dividend is expected to be distributed through Euroclear Sweden AB on May 26, 2026.
お知らせ • May 05+ 2 more updatesPrevas AB to Report First Half, 2026 Results on Jul 17, 2026Prevas AB announced that they will report first half, 2026 results on Jul 17, 2026
お知らせ • Apr 21Prevas AB to Report Q1, 2026 Results on May 05, 2026Prevas AB announced that they will report Q1, 2026 results at 8:30 AM, Central European Standard Time on May 05, 2026
お知らせ • Feb 11Prevas AB Proposes Dividend for the Year Ended December 2025Th Board of Prevas AB proposed a dividend of SEK 4.00 per share (SEK 4.75) per share for the year ended December 2025.
お知らせ • Jan 28Prevas Strengthens Customer Support with AI AssistancePrevas AB announced taking the next step by integrating AI into its operations and support services - a move that improves both delivery quality and the work environment for support staff. Prevas currently manages the operations and support of production-critical IT systems for several major industrial clients globally. To meet high demands for availability and quick response times, an AI-powered solution is being implemented. It enables rapid access to and reuse of information from previous cases, documentation, and system logs. The AI solution supports Prevas' support teams in their daily work. A large portion of information handling and documentation can be automated, reducing the need for manual searches and repetitive tasks. The AI support is not a standalone project, but a fully integrated part of Prevas' comprehensive offering in operations and system management. It is primarily used to quickly retrieve past solutions, compile information, and prioritize tasks. As the technology is integrated with more systems, its capabilities are expected to become even more powerful and adaptive. The next step is to automate more parts of the support workflow - from case intake and prioritization to AI-driven monitoring that detects anomalies before operations are affected.
お知らせ • Nov 04Prevas AB, Annual General Meeting, Jan 31, 2026Prevas AB, Annual General Meeting, Jan 31, 2026.
お知らせ • Jul 03Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab.Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025. The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025. Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab on April 28, 2025. Prevas has received the necessary regulatory approvals for the acquisition. The acquisition of OIM Sweden AB is expected to have a marginally positive impact on Prevas’ earnings per share in the current fiscal year.
お知らせ • May 15Prevas AB Announces Dividend for the Financial Year 2024, Payable on May 21, 2025Prevas AB Board of Directors' proposal, on a dividend of SEK 4.75 per share for the financial year 2024. The record date for the dividend was set to May 16, 2025, and the dividend is expected to be distributed by Euroclear Sweden AB on May 21, 2025.
お知らせ • May 06+ 2 more updatesPrevas AB to Report First Half, 2025 Results on Jul 17, 2025Prevas AB announced that they will report first half, 2025 results on Jul 17, 2025
お知らせ • May 05Prevas AB to Report Q1, 2025 Results on May 06, 2025Prevas AB announced that they will report Q1, 2025 results at 8:30 AM, Central European Standard Time on May 06, 2025
お知らせ • Apr 29Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab.Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025. The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025.
お知らせ • Apr 11Prevas AB Proposes Dividend, Payable on May 21, 2025Prevas AB at its Annual General Meeting to be held on May 14, 2025, Board of Directors proposed that a dividend of SEK 4.75 per share, totaling SEK 61,204,842.50, will be paid and that the remaining available earnings of approximately SEK 167,943,121, be carried forward. The record date for the payment is proposed to be May 16, 2025, and if the Annual General Meeting decides in accordance with the proposal, the dividend is expected to be paid through Euroclear Sweden AB on May 21, 2025.
お知らせ • Feb 18Biosensor Launches Enhanced Detection System for Border Controls Biosens®?900Biosensor launched an enhanced detection system for drugs and explosive substances from the Biosensor Applications - will be introduced during the spring. The instrument has been developed, tested and certified in close cooperation with Prevas. The BIOSENS®?900 is a portable instrument that is used to detect traces of drugs and explosives. The analysis is used to confirm suspected and make it easier to continue searching for prohibited substances. The system is used by customers all over the world, above all for checking goods, containers and luggage at border controls and customs filters. The Biosens series has been on the market for more than 20 years, with the BIOSENS®?900 representing the third generation of the instrument. Prevas has long supported Biosensor Applications with the management and further development of the system's software platform, and they were also commissioned to assist with the development and launch of the new instrument model. The BIOSENS®? 900 has been updated in several areas. The system is now battery-powered and the handling of consumables has been simplified. Its size and weight have been reduced by more than 30%, and the instrument has gained an entirely new platform for electronics and mechanics. The software platform has also been adapted to support new features and future-proof production.
お知らせ • Feb 11Prevas AB Proposes Dividend for the Year Ended December 2024The board of Prevas AB proposed a dividend of SEK 4.75 per share (SEK 4.75) for the year ended December 2024.
お知らせ • Feb 06Prevas AB to Report Fiscal Year 2024 Results on Feb 11, 2025Prevas AB announced that they will report fiscal year 2024 results at 8:30 AM, Central European Standard Time on Feb 11, 2025
お知らせ • Nov 05Prevas AB, Annual General Meeting, May 14, 2025Prevas AB, Annual General Meeting, May 14, 2025.